Delos Cosgrove Purchases Shares in AMWL

Delos Cosgrove has made a significant move by purchasing 14,501 shares of AMWL on June 16, 2026. The shares were acquired at a spot trading price of $8.58, although the transaction was recorded with a price of $0.0, indicating it might have been part of a stock-based compensation or similar program.

Insider Buying and Selling at American Well Corporation

Several insiders, including Delos Cosgrove, Derek Ross, Stephen Schlegel, Rivka Goldwasser, Deborah Jackson, and Robert Thomas Webb, each acquired 14,501 shares of AMWL on June 16, 2026. These transactions were not part of any pre-planned trading programs.

Other Institutional Activity in AMWL

Institutional investors have shown varied interest in AMWL. Senvest Management, LLC, significantly increased its holdings by adding 773,834 shares, bringing its total to 1,136,558 shares valued at approximately $5,978,295. In contrast, Morgan Stanley slightly reduced its position by 18,015 shares, now holding 1,156,453 shares worth about $6,082,943. Cable Car Capital, LP, also upped its stake by 449,301 shares to 1,002,650 shares, valued at roughly $5,273,939. Vanguard Capital Management LLC established a new position with 567,271 shares valued at $2,983,845.

American Well Corporation Stock Down 28.1%

AMWL shares are trading at $8.58. The stock has seen various institutional movements, reflecting diverse investor sentiment. With a market cap and other financial metrics not provided, investors are left to consider the current trading dynamics and insider activities.

Analysts Set New Price Targets

Analysts have maintained a cautious stance on AMWL. On May 6, 2026, both TD Cowen and Morgan Stanley maintained their 'hold' ratings with price targets of $8.0 and $6.5, respectively. Stifel also maintained a 'hold' rating with a $5.0 target on February 13, 2026. Wells Fargo stands out with a 'buy' rating and a $9.0 target from November 5, 2025.

Bottom Line

Delos Cosgrove's purchase of AMWL shares highlights ongoing insider interest in the company. Institutional investors have shown mixed actions, with some increasing their stakes significantly. Analyst ratings suggest a cautious outlook, with several firms maintaining 'hold' ratings and price targets reflecting a range of expectations. As always, it's important to remember that insider and institutional activities provide insights into company sentiment but are not definitive buy or sell signals.